CME GROUP INC. Cash & Equivalents 2006-2025 | CME
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is CME GROUP INC.'s current cash & equivalents?
CME GROUP INC. (CME) annual cash & equivalents for 2024 was $2.89B, a 0.67% decline from 2023. CME GROUP INC. cash & equivalents for the quarter ending September 30, 2025 was $2.45B.
What was CME GROUP INC.'s cash & equivalents in 2023?
CME GROUP INC. annual cash & equivalents for 2023 was $2.91B, a 7.05% increase from 2022.
What was CME GROUP INC.'s cash & equivalents in 2022?
CME GROUP INC. annual cash & equivalents for 2022 was $2.72B, a 4.05% decline from 2021.
What is CME GROUP INC.'s 5-year cash & equivalents CAGR?
CME GROUP INC. cash & equivalents grew at a compound annual growth rate (CAGR) of 13.27% from FY2019 to FY2024, going from $1.55B to $2.89B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $2.89B | -0.7% | 10-K |
| FY2023 | $2.91B | +7.1% | 10-K |
| FY2022 | $2.72B | -4.0% | 10-K |
| FY2021 | $2.83B | +73.6% | 10-K |
| FY2020 | $1.63B | +5.3% | 10-K |
| FY2019 | $1.55B | +12.9% | 10-K |
| FY2018 | $1.37B | -27.8% | 10-K |
| FY2017 | $1.90B | +1.9% | 10-K |
| FY2016 | $1.87B | +10.4% | 10-K |
| FY2015 | $1.69B | +23.9% | 10-K |
| FY2014 | $1.37B | -44.7% | 10-K |
| FY2013 | $2.47B | +53.9% | 10-K |
| FY2012 | $1.60B | +54.0% | 10-K |
| FY2011 | $1.04B | +21.9% | 10-K |
| FY2010 | $855.2M | +228.2% | 10-K |
| FY2009 | $260.6M | -12.5% | 10-K |
| FY2008 | $297.9M | -64.8% | 10-K |
| FY2007 | $845.3M | -12.8% | 10-K |
| FY2006 | $969.5M | - | 10-K |